Cash flow RadNet, Inc.

Stocks

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq 01:30:00 26/09/2026 am IST			5-day change	1st Jan Change
70.79 ^USD	-0.73%		-8.99%	-0.78%

16/09	RadNet, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 07:45 AM
11/08	B. Riley Adjusts Price Target on RadNet to $96 From $83, Maintains Buy Rating	MT

09d5ae382a58b42e64f9ba44.l4xhv_p-Yk1tIlFWJ4Ocak4KpbOc2vcTyjMkzpH4Dt0.r-YGh4IUJiYrZyYFb-f3LQ9-3dzwtINnk1JRt6K7e5Xd1Qz5tyZUeT5GHA

Published financial data: RADNET, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	117.59Cr	127.8Cr	146.32Cr	169.31Cr	191.47Cr
Other Revenues, Total	15Cr	15Cr	15Cr	14Cr	13Cr
Total Revenues	132.42Cr	143.01Cr	161.66Cr	182.97Cr	204.02Cr
Cost of Goods Sold, Total	100.13Cr	114.13Cr	124.91Cr	146.91Cr	168.13Cr
Gross Profit	32Cr	29Cr	37Cr	36Cr	36Cr
Selling General & Admin Expenses, Total	12Cr	12Cr	12Cr	11Cr	12Cr
Stock-Based Compensation (IS)	-	-	2.46Cr	-	-
Depreciation & Amortization - (IS)	9.67Cr	12Cr	13Cr	14Cr	15Cr
Other Operating Expenses, Total	22Cr	24Cr	27Cr	25Cr	27Cr
Operating Income	10Cr	4.98Cr	9.7Cr	11Cr	9.08Cr
Interest Expense, Total	-2.72Cr	-1.12Cr	-7.27Cr	-8.79Cr	-7.7Cr
Net Interest Expenses	-2.72Cr	-1.12Cr	-7.27Cr	-8.79Cr	-7.7Cr
Income (Loss) On Equity Invest.	1.1Cr	1.04Cr	64.27L	1.45Cr	1.49Cr
Other Non Operating Income (Expenses)	-14.38L	-18.33L	63.54L	2.49Cr	3.21Cr
EBT, Excl. Unusual Items	8.66Cr	4.72Cr	3.71Cr	6.41Cr	6.07Cr
Restructuring Charges	-7L	-9L	-37.78L	-19.02L	-31.45L
Merger & Related Restructuring Charges	-	-	-	-	-74.46L
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	1.68Cr	-	-
Gain (Loss) On Sale Of Assets	-12.46L	-25.29L	-21.87L	-22.76L	-96.58L
Asset Writedown	-	-	-90.96L	-37.53L	-85.63L
Other Unusual Items	-2.57Cr	-7L	-	-1.13Cr	-
EBT, Incl. Unusual Items	5.89Cr	4.3Cr	3.88Cr	4.49Cr	3.19Cr
Income Tax Expense	1.46Cr	93.61L	84.73L	60.26L	1.49Cr
Earnings From Continuing Operations	4.43Cr	3.36Cr	3.03Cr	3.88Cr	1.7Cr
Net Income to Company	4.43Cr	3.36Cr	3.03Cr	3.88Cr	1.7Cr
Minority Interest	-1.96Cr	-2.3Cr	-2.73Cr	-3.6Cr	-3.57Cr
Net Income - (IS)	2.47Cr	1.06Cr	30.44L	27.93L	-1.87Cr
Net Income to Common Incl Extra Items	2.47Cr	1.06Cr	30.44L	27.93L	-1.87Cr
Net Income to Common Excl. Extra Items	2.47Cr	1.06Cr	30.44L	27.93L	-1.87Cr
Per Share Items
Net EPS - Basic	0.47	0.19	0.05	0.04	-0.25
Basic EPS - Continuing Operations	0.47	0.19	0.05	0.04	-0.25
Basic Weighted Average Shares Outstanding	5.25Cr	5.63Cr	6.36Cr	7.3Cr	7.52Cr
Net EPS - Diluted	0.46	0.17	0.05	0.04	-0.25
Diluted EPS - Continuing Operations	0.46	0.17	0.05	0.04	-0.25
Diluted Weighted Average Shares Outstanding	5.34Cr	5.73Cr	6.47Cr	7.48Cr	7.52Cr
Normalized Basic EPS	0.66	0.12	-0.06	0.05	0.03
Normalized Diluted EPS	0.65	0.11	-0.06	0.05	0.03
Supplemental Items
EBITDA	20Cr	17Cr	23Cr	25Cr	24Cr
EBITA	11Cr	5.99Cr	11Cr	13Cr	11Cr
EBIT	10Cr	4.98Cr	9.7Cr	11Cr	9.08Cr
EBITDAR	32Cr	29Cr	34Cr	36Cr	36Cr
Total Revenues (As Reported)	-	-	-	182.97Cr	204.02Cr
Effective Tax Rate - (Ratio)	24.73	21.79	21.83	13.43	46.58
Current Domestic Taxes	-21.91L	4L	34.42L	23.75L	40.39L
Current Foreign Taxes	18T	87T	6L	13.02L	10.22L
Total Current Taxes	-21.73L	5L	40.8L	36.77L	50.61L
Deferred Domestic Taxes	1.67Cr	1.23Cr	62.36L	30.23L	1.15Cr
Deferred Foreign Taxes	-	-34.3L	-18.43L	-7L	-17.15L
Total Deferred Taxes	1.67Cr	89.03L	43.93L	23.49L	98.01L
Normalized Net Income	3.45Cr	65.26L	-41.29L	40.1L	22.52L
Interest on Long-Term Debt	46.46L	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	-	13.08L	1.5Cr	2.02Cr
Net Rental Expense, Total	12Cr	12Cr	12Cr	11Cr	12Cr
Imputed Operating Lease Interest Expense	2.05Cr	75.88L	4.55Cr	4.81Cr	3.99Cr
Imputed Operating Lease Depreciation	10Cr	12Cr	7.21Cr	6.21Cr	7.62Cr
Stock-Based Comp., COGS (Total)	2.52Cr	2.38Cr	-	2.69Cr	4.47Cr
Stock-Based Comp., Other (Total)	-	-	2.68Cr	29.7L	99.27L
Total Stock-Based Compensation	2.52Cr	2.38Cr	2.68Cr	2.98Cr	5.46Cr

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	13Cr	13Cr	34Cr	74Cr	77Cr
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	13Cr	13Cr	34Cr	74Cr	77Cr
Accounts Receivable, Total	14Cr	17Cr	16Cr	19Cr	20Cr
Other Receivables	53.84L	1.9Cr	2.53Cr	4.19Cr	1.26Cr
Total Receivables	14Cr	19Cr	19Cr	23Cr	21Cr
Prepaid Expenses	4.92Cr	5.4Cr	4.77Cr	5.15Cr	5.2Cr
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	32Cr	37Cr	58Cr	101.93Cr	103.21Cr
Gross Property Plant And Equipment	174.55Cr	192.42Cr	203.73Cr	227.02Cr	244.99Cr
Accumulated Depreciation	-68Cr	-75Cr	-84Cr	-94Cr	-95Cr
Net Property Plant And Equipment	106.85Cr	116.95Cr	120.04Cr	133.45Cr	149.8Cr
Long-term Investments	4.22Cr	5.79Cr	9.27Cr	10Cr	13Cr
Goodwill	51Cr	68Cr	68Cr	71Cr	91Cr
Other Intangibles, Total	5.66Cr	11Cr	9.06Cr	8.14Cr	15Cr
Deferred Tax Assets Long-Term	1.49Cr	-	-	-	-
Deferred Charges Long-Term	21.35L	22.8L	16.43L	22.65L	16.84L
Other Long-Term Assets, Total	3.6Cr	5.32Cr	4.63Cr	3.46Cr	4.03Cr
Total Assets	205.85Cr	243.39Cr	269.05Cr	328.67Cr	375.86Cr
Liabilities
Accounts Payable, Total	8.65Cr	10Cr	12Cr	9.64Cr	15Cr
Accrued Expenses, Total	18Cr	27Cr	22Cr	26Cr	27Cr
Current Portion of Long-Term Debt	1.12Cr	1.24Cr	1.8Cr	2.47Cr	2.54Cr
Current Portion of Leases	6.55Cr	5.76Cr	5.6Cr	5.66Cr	6.19Cr
Unearned Revenue Current, Total	1.07Cr	40.21L	46.47L	32.88L	72.72L
Other Current Liabilities	2.35Cr	2.31Cr	1.59Cr	4.36Cr	7.01Cr
Total Current Liabilities	37Cr	47Cr	44Cr	48Cr	59Cr
Long-Term Debt	74Cr	84Cr	81Cr	99Cr	106.45Cr
Long-Term Leases	58Cr	60Cr	61Cr	66Cr	71Cr
Deferred Tax Liability Non Current	-	92.56L	1.58Cr	2.22Cr	2.19Cr
Other Non Current Liabilities	1.64Cr	2.3Cr	67.21L	37.85L	2.25Cr
Total Liabilities	171.23Cr	194.25Cr	187.71Cr	215.33Cr	240.27Cr
Common Stock, Total	5T	6T	7T	7T	8T
Additional Paid In Capital	34Cr	44Cr	72Cr	99Cr	118.04Cr
Retained Earnings	-9.33Cr	-8.26Cr	-7.96Cr	-7.68Cr	-9.54Cr
Comprehensive Income and Other	-2.04Cr	-2.07Cr	-1.25Cr	-90.61L	48.85L
Total Common Equity	23Cr	33Cr	63Cr	90Cr	108.99Cr
Minority Interest	12Cr	16Cr	18Cr	23Cr	27Cr
Total Equity	35Cr	49Cr	81Cr	113.34Cr	135.59Cr
Total Liabilities And Equity	205.85Cr	243.39Cr	269.05Cr	328.67Cr	375.86Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.62Cr	5.78Cr	6.85Cr	7.4Cr	7.76Cr
ECS Total Common Shares Outstanding	5.35Cr	5.77Cr	6.8Cr	7.4Cr	7.74Cr
Book Value / Share	4.27	5.77	9.28	12.19	14.08
Tangible Book Value	-34Cr	-45Cr	-14Cr	11Cr	3.37Cr
Tangible Book Value Per Share	-6.38	-7.81	-2.05	1.49	0.44
Total Debt	139.78Cr	151.35Cr	149.11Cr	172.89Cr	185.89Cr
Net Debt	126.32Cr	138.56Cr	114.86Cr	99Cr	109.16Cr
Debt Equivalent Oper. Leases	98Cr	98Cr	94Cr	88Cr	93Cr
Minority Interest, Total (Incl. Fin. Div)	12Cr	16Cr	18Cr	23Cr	27Cr
Equity Method Investments, Total	4.22Cr	5.79Cr	9.27Cr	10Cr	13Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	2L	2L	2L	2L	2L
Machinery, Total	70Cr	74Cr	83Cr	91Cr	93Cr
Full Time Employees	6.76T	6.95T	7.87T	8.55T	8.84T
Part Time Employees	527	509	569	454	432
Assets under Capital Lease - Gross	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	2.47Cr	1.06Cr	30.44L	27.93L	-1.87Cr
Depreciation & Amortization - CF	17Cr	17Cr	18Cr	13Cr	20Cr
Amortization of Goodwill and Intangible Assets - (CF)	44L	1.01Cr	1.22Cr	1.25Cr	1.61Cr
Depreciation & Amortization, Total	17Cr	18Cr	19Cr	14Cr	21Cr
Amortization of Deferred Charges, Total - (CF)	32.54L	26.93L	29.87L	30.93L	30.14L
(Gain) Loss From Sale Of Asset	12.46L	25.29L	21.87L	22.76L	96.58L
(Gain) Loss on Sale of Investments - (CF)	-2.17Cr	-3.96Cr	-86.23L	80.06L	71.12L
Asset Writedown & Restructuring Costs	1.97Cr	-	90.95L	37.53L	85.63L
(Income) Loss On Equity Investments - (CF)	-62.6L	-59.52L	91.76L	-99.26L	-58.03L
Stock-Based Compensation (CF)	2.52Cr	2.38Cr	2.68Cr	2.98Cr	5.46Cr
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	2.48Cr	2.63Cr	2.7Cr	11Cr	3.81Cr
Change In Accounts Receivable	-58.9L	-3.01Cr	26.5L	-2.18Cr	-95.6L
Change In Accounts Payable	99.15L	4.98Cr	1.51Cr	3.71Cr	5.24Cr
Change in Unearned Revenues	-2.83Cr	-73.16L	6L	-13.59L	28.13L
Change In Deferred Taxes	1.98Cr	1.34Cr	60.56L	64.54L	1.08Cr
Change in Other Net Operating Assets	-8.77Cr	-8.44Cr	-6.47Cr	-7.69Cr	-6.62Cr
Cash from Operations	15Cr	15Cr	22Cr	23Cr	30Cr
Capital Expenditure	-14Cr	-12Cr	-18Cr	-19Cr	-21Cr
Sale of Property, Plant, and Equipment	6L	39.04L	83T	2L	12.88L
Cash Acquisitions	-7.77Cr	-13Cr	-1.09Cr	-4.37Cr	-13Cr
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-51.3L	-	-	-	-
Investment in Marketable and Equity Securities, Total	-14.41L	-14.41L	-1.4Cr	-14.96L	-41.47L
Other Investing Activities, Total	-	-	-	-	56.67L
Cash from Investing	-22Cr	-25Cr	-20Cr	-23Cr	-34Cr
Long-Term Debt Issued, Total	85Cr	15Cr	-	86Cr	9.9Cr
Total Debt Issued	85Cr	15Cr	-	86Cr	9.9Cr
Long-Term Debt Repaid, Total	-75Cr	-5.38Cr	-4.4Cr	-70Cr	-2.78Cr
Total Debt Repaid	-75Cr	-5.38Cr	-4.4Cr	-70Cr	-2.78Cr
Issuance of Common Stock	5L	3L	25Cr	22Cr	54.49L
Other Financing Activities, Total	97.09L	-9L	-63.46L	1.36Cr	-44.62L
Cash from Financing	10Cr	9.36Cr	20Cr	40Cr	7.22Cr
Foreign Exchange Rate Adjustments	-65T	1L	-3L	-5L	33T
Net Change in Cash	3.26Cr	-67.72L	21Cr	40Cr	2.72Cr
Supplemental Items
Cash Interest Paid	2.9Cr	3.92Cr	6.47Cr	8.46Cr	7.23Cr
Cash Income Tax Paid (Refund)	19.5L	6L	15.87L	41.7L	45.61L
Levered Free Cash Flow	9.12Cr	16Cr	2.73Cr	-94.91L	18Cr
Unlevered Free Cash Flow	10Cr	17Cr	6.97Cr	4.23Cr	23Cr
Change In Net Working Capital	1.3Cr	-4.89Cr	3.06Cr	76.21L	-12Cr
Net Debt Issued / Repaid	9.45Cr	9.42Cr	-4.4Cr	17Cr	7.12Cr

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	3.39	1.39	2.36	2.35	1.61
Return on Total Capital	4.09	1.66	2.81	2.72	1.87
Return On Equity %	14.66	8.02	4.65	3.99	1.37
Return on Common Equity	12.53	3.79	0.63	0.36	-1.87
Margin Analysis
Gross Profit Margin %	24.38	20.19	22.74	19.71	17.59
SG&A Margin	9.21	8.6	7.28	6.02	5.69
EBITDA Margin %	15.17	11.59	13.94	13.68	11.91
EBITA Margin %	8.2	4.19	6.75	6.83	5.24
EBIT Margin %	7.87	3.48	6	6.15	4.45
Income From Continuing Operations Margin %	3.35	2.35	1.88	2.12	0.84
Net Income Margin %	1.87	0.74	0.19	0.15	-0.91
Net Avail. For Common Margin %	1.87	0.74	0.19	0.15	-0.91
Normalized Net Income Margin	2.61	0.46	-0.26	0.22	0.11
Levered Free Cash Flow Margin	6.89	11.52	1.69	-0.52	8.84
Unlevered Free Cash Flow Margin	7.93	11.82	4.31	2.31	11.05
Asset Turnover
Asset Turnover	0.69	0.64	0.63	0.61	0.58
Fixed Assets Turnover	1.36	1.28	1.36	1.44	1.44
Receivables Turnover (Average Receivables)	8.89	8.48	8.87	9.69	9.92
Short Term Liquidity
Current Ratio	0.87	0.79	1.32	2.12	1.76
Quick Ratio	0.73	0.67	1.22	2.02	1.67
Operating Cash Flow to Current Liabilities	0.4	0.31	0.5	0.49	0.51
Days Sales Outstanding (Average Receivables)	41.07	43.04	41.17	37.78	36.81
Average Days Payable Outstanding	28.53	30.24	32.96	27.32	27.1
Long Term Solvency
Total Debt/Equity	403.8	307.96	183.33	152.54	137.1
Total Debt / Total Capital	80.15	75.49	64.71	60.4	57.82
LT Debt/Equity	381.67	293.71	174.24	145.36	130.65
Long-Term Debt / Total Capital	75.76	72	61.5	57.56	55.11
Total Liabilities / Total Assets	83.18	79.81	69.77	65.52	63.93
EBIT / Interest Expense	3.84	4.44	1.33	1.28	1.18
EBITDA / Interest Expense	11.89	25.74	4.72	4.1	4.66
(EBITDA - Capex) / Interest Expense	6.81	15.09	2.29	1.96	1.89
Total Debt / EBITDA	4.33	5.24	4.35	4.79	5.18
Net Debt / EBITDA	3.91	4.8	3.35	2.74	3.04
Total Debt / (EBITDA - Capex)	7.56	8.94	8.96	10.02	12.76
Net Debt / (EBITDA - Capex)	6.83	8.18	6.9	5.73	7.49
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.59	8	13.05	13.18	11.51
Gross Profit, 1 Yr. Growth %	34.3	43.73	18.63	9.39	-0.34
EBITDA, 1 Yr. Growth %	51.97	-17.52	35.98	11.12	-2.83
EBITA, 1 Yr. Growth %	121.19	-44.82	82.1	14.57	-14.24
EBIT, 1 Yr. Growth %	129.52	-52.18	94.53	16.09	-19.04
Earnings From Cont. Operations, 1 Yr. Growth %	-2.63T	-24.17	-9.73	28.02	-56.11
Net Income, 1 Yr. Growth %	-266.62	-56.93	-71.42	-8.25	-767.81
Normalized Net Income, 1 Yr. Growth %	-442.61	-81.1	-163.26	-197.12	-40.17
Diluted EPS Before Extra, 1 Yr. Growth %	-257.75	-62.36	-72.35	-20.13	-753.77
Accounts Receivable, 1 Yr. Growth %	4.23	23.17	-1.59	13.51	7.8
Net Property, Plant and Equip., 1 Yr. Growth %	21.01	9.45	2.65	11.17	12.25
Total Assets, 1 Yr. Growth %	15.21	18.24	10.54	22.16	14.36
Tangible Book Value, 1 Yr. Growth %	-5.01	32.03	-69.09	-179.13	-69.43
Common Equity, 1 Yr. Growth %	38.11	45.47	89.4	43.07	20.79
Cash From Operations, 1 Yr. Growth %	-36.05	-2.06	50.85	5.51	28.24
Capital Expenditures, 1 Yr. Growth %	46.41	-13.36	47.84	6.49	13.39
Levered Free Cash Flow, 1 Yr. Growth %	-47.8	80.54	-83.45	-71.95	254.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-47.68	61.06	-58.77	392.49	119.64
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.11	14.12	10.49	13.11	12.34
Gross Profit, 2 Yr. CAGR %	44.57	47.79	35.26	14.88	6.33
EBITDA, 2 Yr. CAGR %	14.04	11.96	5.9	22.92	6.74
EBITA, 2 Yr. CAGR %	18.79	10.48	0.24	44.44	4.97
EBIT, 2 Yr. CAGR %	18.77	4.77	-3.55	50.28	3.47
Earnings From Cont. Operations, 2 Yr. CAGR %	37.5	338.36	-17.26	7.5	-25.04
Net Income, 2 Yr. CAGR %	29.45	-15.29	-64.91	-48.79	147.54
Normalized Net Income, 2 Yr. CAGR %	70.47	-19.52	-65.42	-21.61	-56.15
Diluted EPS Before Extra, 2 Yr. CAGR %	25.94	-22.94	-67.74	-53.01	128.51
Accounts Receivable, 2 Yr. CAGR %	-6.58	13.3	10.09	5.69	10.62
Net Property, Plant and Equip., 2 Yr. CAGR %	14.62	15.08	5.99	6.82	11.71
Total Assets, 2 Yr. CAGR %	11.8	16.72	14.33	16.21	18.19
Tangible Book Value, 2 Yr. CAGR %	1.23	11.99	-36.12	-50.54	-50.82
Common Equity, 2 Yr. CAGR %	22.84	41.74	65.99	64.61	31.46
Cash From Operations, 2 Yr. CAGR %	19.71	-20.86	21.55	26.15	16.32
Capital Expenditures, 2 Yr. CAGR %	36.36	12.62	13.18	25.48	9.89
Levered Free Cash Flow, 2 Yr. CAGR %	-12.56	-2.92	-45.33	-68.54	507.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-14.97	-8.21	-18.51	-35.01	145.04
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.74	7.41	13.76	11.38	12.57
Gross Profit, 3 Yr. CAGR %	44.24	23.18	40.62	21.52	9.53
EBITDA, 3 Yr. CAGR %	23.14	2.37	19.45	7.61	13.6
EBITA, 3 Yr. CAGR %	42.67	-8	30.5	4.81	21.27
EBIT, 3 Yr. CAGR %	44.28	-12.3	28.77	2.6	22.14
Earnings From Cont. Operations, 3 Yr. CAGR %	5.14	12.76	158.86	-4.31	-20.25
Net Income, 3 Yr. CAGR %	-8.47	-10.3	-41.02	-51.66	20.54
Normalized Net Income, 3 Yr. CAGR %	102.81	-18.1	-25.73	-51.21	-29.86
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.34	-15.79	-45.24	-56.36	13.02
Accounts Receivable, 3 Yr. CAGR %	-3.2	2.44	8.1	11.22	6.39
Net Property, Plant and Equip., 3 Yr. CAGR %	45.66	12.87	10.78	7.69	8.6
Total Assets, 3 Yr. CAGR %	22.88	13.9	14.62	16.88	15.59
Tangible Book Value, 3 Yr. CAGR %	1	10.6	-27.08	-31.39	-57.87
Common Equity, 3 Yr. CAGR %	21.64	29.97	56.12	57.97	48.47
Cash From Operations, 3 Yr. CAGR %	8.59	11.96	-1.87	15.95	26.84
Capital Expenditures, 3 Yr. CAGR %	24.08	17.22	23.32	10.9	21.31
Levered Free Cash Flow, 3 Yr. CAGR %	32.94	11.35	-46.17	-52.97	23.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.12	5.21	-29.7	-26.12	31.03
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.4	9.17	10.64	9.65	13.19
Gross Profit, 5 Yr. CAGR %	12.03	19.24	27.85	18.47	22.11
EBITDA, 5 Yr. CAGR %	13.07	6.7	15.93	10.14	12.94
EBITA, 5 Yr. CAGR %	19.42	1.51	23.89	10.19	16.83
EBIT, 5 Yr. CAGR %	19.86	-1.23	22.81	8.78	14.87
Earnings From Cont. Operations, 5 Yr. CAGR %	40.82	74.54	-4.47	10.63	57.68
Net Income, 5 Yr. CAGR %	27.88	188.81	-37.63	-28.32	4.68
Normalized Net Income, 5 Yr. CAGR %	41.29	-14.58	-0.05	-19.52	-25.9
Diluted EPS Before Extra, 5 Yr. CAGR %	25.12	174.16	-40.83	-33.32	-3.03
Accounts Receivable, 5 Yr. CAGR %	-3.83	1.36	1.91	3.73	9.1
Net Property, Plant and Equip., 5 Yr. CAGR %	33.96	36.78	28.27	10.41	11.15
Total Assets, 5 Yr. CAGR %	19.37	22.87	19.39	14.82	16.04
Tangible Book Value, 5 Yr. CAGR %	7.88	13.86	-15.91	-19.84	-37.71
Common Equity, 5 Yr. CAGR %	36.4	40.16	37.75	42.85	45.74
Cash From Operations, 5 Yr. CAGR %	10.28	0.58	13.6	17.44	5.03
Capital Expenditures, 5 Yr. CAGR %	18.4	14.26	19.6	20.46	17.76
Levered Free Cash Flow, 5 Yr. CAGR %	10.89	20.39	-6.83	-39.73	0.62
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.52	14.2	2.34	-21.85	2.36